Acacia Pharma Ltd. - Product Pipeline Review - 2015

01:13 EDT 15 Apr 2015 | BioPortfolio Reports

Recently added to the BioPortfolio report store, Acacia Pharma Ltd. - Product Pipeline Review - 2015 is a new report from Global Markets Direct published on 2015-03-10. This 27-page report is available in PDF from $1500.

Acacia Pharma Ltd. - Product Pipeline Review - 2015


Global Markets Direct’s, ‘Acacia Pharma Ltd. - Product Pipeline Review - 2015’, provides an overview of the Acacia Pharma Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Acacia Pharma Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- The report provides brief overview of Acacia Pharma Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Acacia Pharma Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Acacia Pharma Ltd.’s pipeline products

Reasons to buy

- Evaluate Acacia Pharma Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Acacia Pharma Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Acacia Pharma Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Acacia Pharma Ltd. and exploit collaboration and partnership opportunities
- Identify emerging…

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Acacia Pharma Ltd. Snapshot 4
Acacia Pharma Ltd. Overview 4
Key Information 4
Key Facts 4
Acacia Pharma Ltd. - Research and Development Overview 5
Key Therapeutic Areas 5
Acacia Pharma Ltd. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Combination Treatment Modalities 9
Acacia Pharma Ltd. - Pipeline Products Glance 10
Acacia Pharma Ltd. - Late Stage Pipeline Products 10
Phase III Products/Combination Treatment Modalities 10
Acacia Pharma Ltd. - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Acacia Pharma Ltd. - Drug Profiles 12
APD-421 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
(formoterol fumarate + megestrol acetate) 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
APD-403 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
APD-515 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Acacia Pharma Ltd. - Pipeline Analysis 17
Acacia Pharma Ltd. - Pipeline Products by Target 17
Acacia Pharma Ltd. - Pipeline Products by Route of Administration 18
Acacia Pharma Ltd. - Pipeline Products by Molecule Type 19
Acacia Pharma Ltd. - Pipeline Products by Mechanism of Action 20
Acacia Pharma Ltd. - Recent Pipeline Updates 21
Acacia Pharma Ltd. - Dormant Projects 23
Acacia Pharma Ltd. - Discontinued Pipeline Products 24
Discontinued Pipeline Product Profiles 24
APD-405 24
Acacia Pharma Ltd. - Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
Coverage 26
Secondary Research 26
Primary Research 26
Expert Panel Validation 26
Contact Us 26
Disclaimer 27

For more information open Acacia Pharma Ltd. - Product Pipeline Review - 2015.


Original Article: Acacia Pharma Ltd. - Product Pipeline Review - 2015


More From BioPortfolio on "Acacia Pharma Ltd. - Product Pipeline Review - 2015"

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...